1/60
Looks like no tags are added yet.
NEOPLASIA → 3 CARACTÉRISTIQUES
NEW CLONE OF CELLS → UNCONTROLLED + EXCESSIVE + AUTONOMOUS GROWTH
NEOPLASIA = DANGER ?
PEUT ETRE MALIN COMME BENIN
CANCER SYNONYME DE
MALIGNANT NEOPLASIA
HYPERTROPHY =
CELL SIZE ++
HYPERPLASIA =
CELL NUMBER ++
METAPLASIA =
REPLACEMENT OF 1 MATURE CELL TYPE BY ANOTHER MATURE CELL TYPE
EXEMPLE METAPLASIA
RESPIRATORY EPITH° IN SMOKERS
METAPLASIA RISK CANCER
LOW RISK OF CANCER
2 TRIGGERS → DYSPLASIA
ABNORMAL CELLS + DISORGANIZED TISSUE
DYSPLASIA CONSIDÉRÉ COMME ?
PREMALIGNANT
NEOPLASIA CANCER RISK →
HIGH CANCER RISK
TRIGGER = LEUKOPLAKIA + ABNORMAL CELL SIZE AND ORGANIZATION
ORAL EPITHELIAL DYSPLASIA
ANAPLASIA
LOSS OF DIFFERENCIATION
3 CARACTÉRISTIQUES ANAPLASIA
BIG NUCLEUS + DISORGANIZED + NON REVERSIBLE
SI → LARGE NUCLEI + MANY MITOSES + HIGHLY IRREGULAR CELLS ?
ANAPLASTIC CARCINOMA
ORDRE DE GRAVITÉ ENTRE DYS° ANA° ET META°
1→ META → REVERSIBLE
2 → DYS° → PREMALIGNANT
3 → ANA° → MALIGNANT + LOSS OF DIFFERENTIATION
SI → SLOW GROWTH + WELL DIFFERENCIATED + NORMAL LOOKING CELLS
BENIGN
5 SIGNES → MALIGNANT
FAST GROWTH + ABNROMAL CELLS + DISORGANIZED TISSUE + INVASION + METASTASIS
-OMA
BENIGN TUMOR
-CARCINOMA
MALIGNANT EPITHELIAL TUMOR
-SARCOMA
MALIGNANT TUMOR OF BONE / CONNECTIVE TISSUE / MUSCLE
-BLASTOMA
MALIGNANT TUMOR OF DEVELOPPING CELLS
MALINGANT CELLS STAY ABOVE THE BASAL MEMBRANE →
CARCINOMA IN SITU
MALIGANT CELLS CROSS THE CELL MEMBRANE
INVASIVE CARCINOMA
TRIGGER → SAME MALIGNANT CELLS IN A DISTANT ORGAN
METASTASIS
REGIONAL LYMPH NODE INVOLVEMENT →
LYMPHATIC SPREAD
LYMPHATIC SPREAD CAN CAUSE →
ADENOPATHY / LYMPHADENOPATHY
MALIGNANT CELLS IN A DISTANT ORGAN VIA BLOOD ? ORGANES LES + TOUCHÉS ?
HEMATOGENOUS SPREAD
→ LUNG + LIVER
TRIGGER : BONE METASTASIS + DESTRUCTIVE RADIOLUCENT LESIONS →
OSTEOLYTIC
TRIGGER : BONE METASTASIS + SCLEROTIC LESIONS ?
OSTEOBLASTIC
WHY CANCER DEVELOPS
MUTATIONS ACCUMULATE IN CELL DNA
PROTO ONCOGENE
NORMAL GENE → REGULATE CELL GROWTH + DIFFERENCIATION
ONCOGENE
MUTATED PROTO-ONCOGENE → UNCONTROLLED GROWTH
CELL THAT INHIBITS CELL PROLIFERATION ?
TUMOR SUPPRESSOR GENES
3 GROUPES DE CARCINOGENES + EXEMPLE :
CHIMIQUES → TABAC
BIOLOGIQUES → VIRUS
PHYSICAL → RADIATION
HTLV-I ASSOCIÉ À
T-CELL LEUKEMIA/LYMPHOMA
HEPATITIS B/C ASSOCIÉ À
HEPATOCELLULAR CARCINOMA
EBV ASSOCIÉ À ?
BURKITT LYMPHOMA
HODGKIN DISEASE
NASOPHARYNGEAL CARCINOMA
HHV-8 / KSHV ASSOCIÉ À
KAPOSI SARCOMA
HPV 16-18-33-39 ASSOCIÉ À ?
CERVICAL CARCINOMA
ANAL CARCINOMA
HPV 5,8,17 ASSOCIÉ ?
SKIN CANCER
RED-PURPLE ORAL LESIONS + HIV
KAPOSI SARCOMA
(HHV-8 / KHSV)
B-CELL LYMPHOMA + EBV
BURKITT LYMPHOMA
SMOKER + NON HEALING ORAL ULCER
ORAL SQUAMOUS CELL CARCINOMA
TUMOR IN HOLLOW ORGAN + OBSTRUCTION
STENOSIS
TUMOR DAMAGES MUCOSA
UNUSUAL BLEEDING
PARANEOPLASTIC SYNDROME
SYMPTOMS DUE TO SUBSTANCES SECRETES BY A TUMOR
SUSPICIOUS ORAL LESION DEFINITIVE DIAGNOSIS →
BIOPSY
TUMOR MARKER CEA →
ADENOCARCINOMA
TUMOR MARKER AFP
HEPATOCARCINOMA
TUMOR MARKER PSA
PROSTATE CANCER
TNM =
T = TUMOR
N = NODES
M = METASTASIS
TX
CANNOT EVALUATE TUMOR
TIS
CARCINOMA IN SITU
T0
NO PRIMARY TUMORS
T1-T4
PROGRESSIVLY LARGER / EXTENSIVE TUMORS
STAGE I
SMALL LOCALIZED TUMOR
STAGE II
LARGER TUMOR
STAGE III
LYMPH NODE INVOLVEMENT
STAGE IV
METASTASIS
ORAL CANCER + ENLARGED CERVICAL NODE
LYMPHATIC METASTASIS